{{Rsnum
|rsid=2116940
|Chromosome=19
|position=10199716
|Orientation=plus
|GMAF=0.2163
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 88.5 | 11.5 | 0.0
| HCB | 29.2 | 52.6 | 18.2
| JPT | 44.2 | 44.2 | 11.5
| YRI | 56.5 | 39.5 | 4.1
| ASW | 59.6 | 35.1 | 5.3
| CHB | 29.2 | 52.6 | 18.2
| CHD | 32.4 | 52.8 | 14.8
| GIH | 66.3 | 31.7 | 2.0
| LWK | 44.0 | 45.0 | 11.0
| MEX | 65.5 | 32.8 | 1.7
| MKK | 45.4 | 40.8 | 13.8
| TSI | 80.4 | 18.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=G
  |Pval=3E-6
  |OR=19.71
  |ORtxt=[11.4-28.02] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}